A detailed history of Fairmount Funds Management LLC transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Fairmount Funds Management LLC holds 123,538 shares of BCYC stock, worth $1.8 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
123,538
Previous 1,069,199 88.45%
Holding current value
$1.8 Million
Previous $21.6 Million 87.06%
% of portfolio
0.46%
Previous 4.29%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$19.58 - $27.24 $18.5 Million - $25.8 Million
-945,661 Reduced 88.45%
123,538 $2.8 Million
Q2 2024

Aug 14, 2024

BUY
$20.02 - $24.69 $21.4 Million - $26.4 Million
1,069,199 New
1,069,199 $21.6 Million

Others Institutions Holding BCYC

About BICYCLE THERAPEUTICS plc


  • Ticker BCYC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,676,100
  • Market Cap $431M
  • Description
  • Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...
More about BCYC
Track This Portfolio

Track Fairmount Funds Management LLC Portfolio

Follow Fairmount Funds Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairmount Funds Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fairmount Funds Management LLC with notifications on news.